Study Finds Cancer Cells Use Glutathione as Fuel to Drive Growth

A new study published in Nature has uncovered an unexpected role for glutathione, an antioxidant traditionally known for protecting cells, as a key fuel source for cancer cells. The research, led by Isaac Harris, PhD, at the Wilmot Cancer Institute, reveals that tumors may be “addicted” to glutathione, opening new possibilities for targeted cancer therapies.

Cancer cells exist in nutrient-poor environments and must adapt to survive. This study shows that, unlike normal cells, cancer cells can break down glutathione and use it as an alternative energy source to support growth and survival. This discovery shifts the long-standing perception of glutathione from purely protective to potentially pro-tumor in certain contexts.

By analyzing breast tumor samples from a biobank, researchers found high concentrations of glutathione within tumor tissues, confirming that cancer cells actively accumulate and utilize it. Further experiments in preclinical models demonstrated that blocking glutathione metabolism significantly slowed tumor growth, suggesting a promising therapeutic strategy.

Importantly, the findings do not imply that antioxidant-rich foods are harmful. Researchers emphasize that whole foods like fruits and vegetables remain essential for overall health, as they help reduce inflammation and support immunity. However, caution may be warranted with high-dose antioxidant supplements, particularly glutathione, as excessive levels could potentially support tumor metabolism.

The study also identified a previously developed drug that can inhibit the tumor’s ability to use glutathione. Scientists are now working to refine this compound and explore combination therapies that could enhance cancer treatment effectiveness without harming healthy cells.

Overall, this research highlights a critical metabolic vulnerability in cancer cells and underscores the complexity of nutrients in disease. Targeting how tumors utilize glutathione could pave the way for more precise and effective cancer therapies in the future.

REFERENCE: Hecht, F., Zocchi, M., Tuttle, E.T. et al. Catabolism of extracellular glutathione supplies cysteine to support tumours. Nature (2026). https://doi.org/10.1038/s41586-026-10268-2